2025-12-19 · Notice · 2025-23409
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FORZINITY (Elamipretide)
Elamipretide
Open attributed record →Federal Register publication year
2025 FDA Federal Register peptide records
6 documents attributed to FDA and HHS and published in 2025, connected only through exact reviewed peptide-name matches.
2025-12-05 · Notice · 2025-22131
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Glucagon + Liraglutide + Semaglutide + Teriparatide + Tirzepatide + Vosoritide
Open attributed record →2025-11-21 · Notice · 2025-20548
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Glucagon + Tirzepatide
Open attributed record →2025-10-02 · Notice · 2025-19281
Pediatric Advisory Committee (PAC); Notice of Meeting; Establishment of a Public Docket; Request for Comments
Exenatide + Linaclotide
Open attributed record →2025-10-02 · Notice · 2025-19345
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Semaglutide
Open attributed record →2025-08-04 · Notice · 2025-14683
Teva Branded Pharmaceutical Products R&D, Inc., et al.; Withdrawal of Approval of 39 New Drug Applications
Exenatide
Open attributed record →